Our Capabilities That Support CAR-T Cell Research
- Human PBMCs isolation, sorting
- Cytotox assay with co-cultured cancer cells
- Proliferation
- Cytokine profile
- Lentivirus packaging
- Transduction efficiency
- In vivo proliferation of effector cells: CAR expression and CFSE assay
- Xenograft tumor growth inhibition (NOG-SCID mice)
- Survival as endpoint
- Whole animal imaging - Biodistribution
Guarantee: We are the only CRO, providing cost-effective reprogramming/CAR-T generation.
Accepting a variety of donor cell types: We have successfully generated iPSC from Fibroblasts, PBMCs, CD34 , LCLs;
Short Period: 2-3 months depending on reprogramming methods, source cells, and species
Additional ‘add-on’ services: Genomic editing, Teratoma Formation, Embryoid Body Formation, Karyotyping, and further Characterization.
CAR-T and iPSCs generation and characterization service
